-
After Copaxone, Is Teva's Future Bleak?
Post on 2/9/17
-
Why Celldex Therapeutics Stock Fell by Almost 10% in January
Post on 2/9/17
-
Synchronoss Technologies Moves Forward After Intralinks Acquisition
Post on 2/9/17
-
Interpace Diagnostics Closes $3.9 Million Public Offering
Post on 2/8/17
-
Helius Medical Technologies Proposes Public Offering of Class A Common Stock
Post on 2/8/17
-
Better Buy: Merck & Co. Inc. vs. GlaxoSmithKline
Post on 2/8/17
-
Better Buy: Kimberly-Clark Corporation vs. Johnson & Johnson
Post on 2/8/17
-
Teva Q4 Earnings: Brace For Impact
Post on 2/8/17
-
Johnson & Johnson Needs To Paint A Heartening Picture With Canvas
Post on 2/8/17
-
Why Teva Pharmaceuticals Industries Just Lost $1.5 Billion In Market Value
Post on 2/8/17
-
ICTV Brands Completes $7M Common Stock Financing
Post on 2/6/17
-
Pfizer May Be Another IBM
Post on 2/6/17
-
Pfizer's New Biosimilar Is Off and Running
Post on 2/6/17
-
Johnson & Johnson Just Raised The Bar For Pharma M&A, Just As The Sector Comes To Life
Post on 2/6/17
-
Merck: Analyzing 2016 Performance And Outlook For 2017
Post on 2/6/17
-
Johnson & Johnson Is Becoming a Far Riskier Investment
Post on 2/6/17
-
Palatin Technologies Closes License Agreement with AMAG Pharmaceuticals
Post on 2/5/17
-
Interpace Diagnostics Prices Public Offering to Raise $3.6 Million
Post on 2/5/17
-
Pernix Therapeutics Provides Update on Arbitration
Post on 2/3/17
-
Interpace Diagnostics Proposes Public Offering of Common Stock
Post on 2/2/17
-
Nestlé to Expand Manufacturing Capacity at Eau Claire Plant
Post on 2/2/17
-
Hemispherx Biopharma Announces $1 Million Registered Direct Offering
Post on 2/2/17
-
5 Things Pfizer's Management Wants You to Know
Post on 2/2/17
-
3 Pharmaceutical Stocks With Bigger Dividends Than Johnson & Johnson
Post on 2/2/17
-
Safeguard Scientifics: Heading To The Future With Internet Of Everything, AI And Cybersecurity
Post on 2/2/17
Philadelphia
